BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Quitmann J, Bloemeke J, Silva N, Bullinger M, Witt S, Akkurt I, Dunstheimer D, Vogel C, Böttcher V, Kuhnle Krahl U, Bettendorf M, Schönau E, Fricke-Otto S, Keller A, Mohnike K, Dörr HG. Quality of Life of Short-Statured Children Born Small for Gestational Age or Idiopathic Growth Hormone Deficiency Within 1 Year of Growth Hormone Treatment. Front Pediatr 2019;7:164. [PMID: 31111024 DOI: 10.3389/fped.2019.00164] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Laron Z. Increase of serum lipoprotein (a), an adverse effect of growth hormone treatment. Growth Horm IGF Res 2022;67:101503. [PMID: 36115257 DOI: 10.1016/j.ghir.2022.101503] [Reference Citation Analysis]
2 Chae HW, Hwang I, Lee J, So CH, Rhie Y, Lim JS, Kwon EB, Yi KH, Kim EY, Jo C, Shim KS, Gil H, Seong M, Nam CM, Moon J, Hwang JS. Height outcomes in Korean children with idiopathic short stature receiving growth hormone treatment. Front Endocrinol 2022;13:925102. [DOI: 10.3389/fendo.2022.925102] [Reference Citation Analysis]
3 Mergulhão B, Almeida JP, Moreira H, Castro-Correia C, Bullinger M, Canavarro MC, Silva N. Quality of Life of Children and Adolescents with Short Stature: The Twofold Contribution of Physical Growth and Adaptive Height-Related Cognitive Beliefs. J Clin Psychol Med Settings 2022. [PMID: 35511326 DOI: 10.1007/s10880-022-09871-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Feng H, Zhao W, Yu H, Wang G, Wang Q. A Clinical Study on the Treatment of Children's Short Stature with Auxiliary Comprehensive Management Combined with Growth Patch. Evid Based Complement Alternat Med 2021;2021:7142006. [PMID: 34745298 DOI: 10.1155/2021/7142006] [Reference Citation Analysis]
5 Constantinides C, Landis SH, Jarrett J, Quinn J, Ireland PJ. Quality of life, physical functioning, and psychosocial function among patients with achondroplasia: a targeted literature review. Disabil Rehabil 2021;:1-13. [PMID: 34403286 DOI: 10.1080/09638288.2021.1963853] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
6 McNamara M, Turner-Bowker DM, Westhead H, Yaworsky A, Palladino A, Gross H, Pleil A, Loftus J. Factors Driving Patient Preferences for Growth Hormone Deficiency (GHD) Injection Regimen and Injection Device Features: A Discrete Choice Experiment. Patient Prefer Adherence 2020;14:781-93. [PMID: 32431492 DOI: 10.2147/PPA.S239196] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
7 de Zwaan M, Fischer-Jacobs J, Wabitsch M, Reinehr T, Meckes-Ferber S, Crosby RD. Development and Psychometric Evaluation of an Instrument Assessing Barriers to Growth Hormone Treatment (BAR-GHT). Front Endocrinol (Lausanne) 2020;11:84. [PMID: 32158432 DOI: 10.3389/fendo.2020.00084] [Reference Citation Analysis]